Stock Worth Mentioning: What Next for AAC Holdings Inc Stock After Reaching Yearly Low?

Stock Worth Mentioning: What Next for AAC Holdings Inc Stock After Reaching Yearly Low?

The stock of AAC Holdings Inc (NYSE:AAC) hit a new 52-week low and has $6.04 target or 13.00% below today’s $6.94 share price. The 6 months bearish chart indicates high risk for the $151.50 million company. The 1-year low was reported on Nov, 9 by Barchart.com. If the $6.04 price target is reached, the company will be worth $19.70M less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 383,244 shares traded hands or 8.50% up from the average. AAC Holdings Inc (NYSE:AAC) has declined 63.20% since April 7, 2016 and is downtrending. It has underperformed by 67.98% the S&P500.

AAC Holdings Inc (NYSE:AAC) Ratings Coverage

Out of 3 analysts covering AAC Holdings Inc (NYSE:AAC), 1 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 33% are positive. AAC Holdings Inc has been the topic of 9 analyst reports since August 3, 2015 according to StockzIntelligence Inc. The firm has “Outperform” rating by William Blair given on Friday, August 21. The firm earned “Underperform” rating on Wednesday, November 9 by Mizuho. Mizuho initiated AAC Holdings Inc (NYSE:AAC) on Monday, August 3 with “Neutral” rating. On Monday, August 15 the stock rating was upgraded by Raymond James to “Strong Buy”. The firm has “Neutral” rating by Mizuho given on Thursday, November 3. The rating was maintained by Mizuho with “Buy” on Monday, July 18. The firm earned “Buy” rating on Monday, September 21 by William Blair. The rating was downgraded by Raymond James on Thursday, November 3 to “Mkt Perform”. The company was upgraded on Wednesday, May 25 by Mizuho.

According to Zacks Investment Research, “AAC Holdings, Inc. is a provider of inpatient substance abuse treatment services for individuals with drug and alcohol addiction. It provides detoxification, residential treatment, partial hospitalization, and intensive outpatient care services. AAC Holdings, Inc. is headquartered in Brentwood, Tennessee.”

Insitutional Activity: The institutional sentiment increased to 2.04 in 2016 Q2. Its up 0.20, from 1.84 in 2016Q1. The ratio increased, as 12 funds sold all AAC Holdings Inc shares owned while 11 reduced positions. 13 funds bought stakes while 34 increased positions. They now own 11.87 million shares or 2.63% more from 11.56 million shares in 2016Q1.
Mondrian Investment owns 104,407 shares or 0.06% of their US portfolio. Highland Capital Mngmt Limited Partnership, a Texas-based fund reported 327,258 shares. Altrinsic Global Advsr Ltd Com holds 0.33% of its portfolio in AAC Holdings Inc (NYSE:AAC) for 504,370 shares. Deutsche Savings Bank Ag holds 0% of its portfolio in AAC Holdings Inc (NYSE:AAC) for 62,115 shares. Blackrock Advsr Limited Co, a Delaware-based fund reported 4,500 shares. Blackrock Ltd Llc, a New Jersey-based fund reported 37,692 shares. Deerfield Management, a New York-based fund reported 2.15 million shares. Moreover, Prudential has 0% invested in AAC Holdings Inc (NYSE:AAC) for 16,893 shares. Summit Creek Advisors has 1% invested in the company for 257,186 shares. The Germany-based Allianz Asset Ag has invested 0% in AAC Holdings Inc (NYSE:AAC). Moreover, Stephens Mgmt Grp Inc Limited Liability Co has 0.64% invested in AAC Holdings Inc (NYSE:AAC) for 847,985 shares. Northern Tru Corp reported 265,293 shares or 0% of all its holdings. Pnc Fincl Svcs Group Inc Inc Inc has 29,300 shares for 0% of their US portfolio. Dnb Asset Mgmt As, a Norway-based fund reported 28,100 shares. Blackrock Institutional Tru Na accumulated 0% or 198,747 shares.

Another recent and important AAC Holdings Inc (NYSE:AAC) news was published by Fool.com which published an article titled: “Here’s Why AAC Holdings Lost Over Half Its Value Today” on November 03, 2016.

AAC Company Profile

AAC Holdings, Inc., incorporated on February 12, 2014, is a well-known provider of inpatient and outpatient substance abuse treatment services for individuals with drug and alcohol addiction. The Firm performs drug testing and diagnostics laboratory services and provides physician services to its clients. As of June 30, 2016, the Company operated 12 residential substance abuse treatment facilities located throughout the United States, focused on delivering clinical care and treatment solutions across 1,139 beds, which includes 636 licensed detoxification beds, and 18 standalone outpatient centers. In addition, the Company focuses on expanding The Oxford Centre facility to accommodate 44 additional residential beds and 48 sober living beds, converting a 100-room hotel in Arlington, Texas into sober living beds. As of June 30, 2016, the Company had begun the development of a 150-bed residential treatment center at the site of a former convent on 96 acres in Ringwood, New Jersey. As of June 30, 2016, the Company’s capacity at its Forterus treatment facility was 14 beds. The Firm is engaged in deploying research treatment programs with structured curricula for detoxification, residential treatment, partial hospitalization and intensive outpatient care.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment